<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: <z:chebi fb="0" ids="35664">Statins</z:chebi> have shown some protective effect after ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> in observational studies </plain></SENT>
<SENT sid="1" pm="."><plain>However, this effect has never been assessed by etiological subtypes </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Observational study using data from the <z:hpo ids='HP_0001297'>Stroke</z:hpo> Unit Data Bank from consecutive patients with <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Variables analyzed: demographic data, <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, treatment with <z:chebi fb="0" ids="35664">statins</z:chebi> at <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo>, <z:hpo ids='HP_0001297'>stroke</z:hpo> severity, <z:hpo ids='HP_0001297'>stroke</z:hpo> subtype, in-hospital complications, length of stay, and functional status at discharge (modified Rankin Scale) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 2742 patients were included, 1539 were men </plain></SENT>
<SENT sid="5" pm="."><plain>Mean age was 69.17 years (SD 12.19) </plain></SENT>
<SENT sid="6" pm="."><plain>Of these, 281 patients (10.2%) were receiving <z:chebi fb="0" ids="35664">statins</z:chebi> when admitted </plain></SENT>
<SENT sid="7" pm="."><plain>The logistic regression analyses showed that previous treatment with <z:chebi fb="0" ids="35664">statins</z:chebi> was an independent predictor for better outcome at discharge among <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0001297'>strokes</z:hpo> (OR, 2.08; 95% CI, 1.39 to 3.1) as well as for the atherothrombotic (OR, 2.79; 95% CI, 1.33 to 5.84) and lacunar <z:hpo ids='HP_0001297'>strokes</z:hpo> (OR, 2.28; 95% CI, 1.15 to 4.52) after adjustment for demographic data, risk factors, previous treatments, <z:hpo ids='HP_0001297'>stroke</z:hpo> subtypes, <z:hpo ids='HP_0001297'>stroke</z:hpo> severity, in-hospital complications and length of stay </plain></SENT>
<SENT sid="8" pm="."><plain>This benefit was not observed either in cardioembolic or in other etiology <z:hpo ids='HP_0001297'>strokes</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Previous treatment with <z:chebi fb="0" ids="35664">statins</z:chebi> is an independent factor associated with good outcomes in patients with ischaemic <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>Atherothrombotic and small vessel <z:hpo ids='HP_0001297'>strokes</z:hpo> show the greatest benefit </plain></SENT>
</text></document>